Payment overview · 2025
General Payments
$6,700.52
8 reported records · 3 companies
Healthcare provider profile · identity verified
Veronica A Anwuri, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · LEES SUMMIT, MO · NPI 1336268648
Verified facts
What the public records show
CMS Open Payments records show Veronica A Anwuri, M.D. received $6,700.52 in general payments during 2025 across 8 reported records.
Amgen Inc. accounted for 98.2% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Nurtec Odt.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 15 claims for Farxiga by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 30 claims for Symbicort by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 133 claims for Eliquis by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported NURTEC ODT as an associated drug or biological on 217574 records involving 54025 distinct recipient NPIs. Public Medicare Part D data also shows 13 claims for Nurtec Odt by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Amgen Inc. | Unresolved — no canonical attribution shown | $6,576.26 | 98.2% | 6 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $81.01 | 1.2% | 1 | 2025 |
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $43.25 | 0.7% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,300.00 | 3 |
| Food and Beverage | $357.27 | 4 |
| Education | $43.25 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $6,576.26 | 6 | 2025 |
Source payment records
|
|||||
| NURTEC ODT Normalized: nurtec odt |
Drug | PFIZER INC. | $81.01 | 1 | 2025 |
Source payment records
|
|||||
| ENHERTU Normalized: enhertu |
Biological | AstraZeneca Pharmaceuticals LP | $43.25 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| NURTEC ODT nurtec odt |
2025 | Nurtec Odt | 2024 | 13 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
15 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | SYMBICORT open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610 |
Symbicort · 2024 Exact normalized brand match · 1 Part D row |
30 | suppressed by CMS |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
133 | 28 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | NURTEC ODT open payments reported associated product |
CMS Open Payments — General Payments 217574 supporting records · 54025 recipient NPIs · example record 1228794063 |
Nurtec Odt · 2024 Exact normalized brand match · 1 Part D row |
13 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 806 | 159 |
| Atorvastatin Calcium | Atorvastatin Calcium | 625 | 164 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 513 | 149 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 453 | 80 |
| Montelukast Sodium | Montelukast Sodium | 453 | 98 |
| Gabapentin | Gabapentin | 435 | 113 |
| Pantoprazole Sodium | Pantoprazole Sodium | 402 | 87 |
| Amlodipine Besylate | Amlodipine Besylate | 399 | 104 |
| Omeprazole | Omeprazole | 393 | 103 |
| Alprazolam | Alprazolam | 392 | 71 |
| Alendronate Sodium | Alendronate Sodium | 340 | 73 |
| Lisinopril | Lisinopril | 313 | 87 |
| Losartan Potassium | Losartan Potassium | 306 | 82 |
| Metformin Hcl Er | Metformin Hcl | 292 | 79 |
| Oxycodone Hcl | Oxycodone Hcl | 266 | 32 |
| Potassium Chloride | Potassium Chloride | 247 | 51 |
| Metformin Hcl | Metformin Hcl | 236 | 59 |
| Hydrochlorothiazide | Hydrochlorothiazide | 235 | 60 |
| Furosemide | Furosemide | 227 | 58 |
| Tizanidine Hcl | Tizanidine Hcl | 217 | 66 |
| Zolpidem Tartrate | Zolpidem Tartrate | 208 | 36 |
| Trazodone Hcl | Trazodone Hcl | 197 | 49 |
| Simvastatin | Simvastatin | 191 | 38 |
| Tramadol Hcl | Tramadol Hcl | 187 | 44 |
| Fluticasone Propionate | Fluticasone Propionate | 186 | 54 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 186 | 24 |
| Famotidine | Famotidine | 182 | 46 |
| Carvedilol | Carvedilol | 181 | 47 |
| Meloxicam | Meloxicam | 181 | 53 |
| Metoprolol Succinate | Metoprolol Succinate | 179 | 53 |
| Sertraline Hcl | Sertraline Hcl | 173 | 44 |
| Pravastatin Sodium | Pravastatin Sodium | 158 | 39 |
| Baclofen | Baclofen | 157 | 30 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 156 | 65 |
| Duloxetine Hcl | Duloxetine Hcl | 156 | 40 |
| Topiramate | Topiramate | 148 | 36 |
| Clonazepam | Clonazepam | 147 | 24 |
| Ozempic | Semaglutide | 145 | 27 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 143 | 22 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 134 | 38 |
| Eliquis | Apixaban | 133 | 28 |
| Allopurinol | Allopurinol | 129 | 33 |
| Nystatin | Nystatin | 128 | 51 |
| Tamsulosin Hcl | Tamsulosin Hcl | 126 | 32 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 120 | 25 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 114 | 15 |
| Lorazepam | Lorazepam | 111 | 33 |
| Escitalopram Oxalate | Escitalopram Oxalate | 110 | 30 |
| Donepezil Hcl | Donepezil Hcl | 108 | 27 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 105 | 15 |
| Spironolactone | Spironolactone | 98 | 29 |
| Pregabalin | Pregabalin | 93 | 22 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 91 | 57 |
| Jardiance | Empagliflozin | 90 | 25 |
| Ezetimibe | Ezetimibe | 88 | 21 |
| Fenofibrate | Fenofibrate Nanocrystallized | 85 | suppressed |
| Metoprolol Tartrate | Metoprolol Tartrate | 85 | 22 |
| Fluconazole | Fluconazole | 84 | 34 |
| Atenolol | Atenolol | 82 | 15 |
| Fluoxetine Hcl | Fluoxetine Hcl | 81 | 17 |
| Ibuprofen | Ibuprofen | 75 | 36 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 74 | 18 |
| Ropinirole Hcl | Ropinirole Hcl | 72 | 14 |
| Synthroid | Levothyroxine Sodium | 72 | 17 |
| Buspirone Hcl | Buspirone Hcl | 70 | 17 |
| Mirtazapine | Mirtazapine | 70 | 16 |
| Fentanyl | Fentanyl | 69 | 13 |
| Xarelto | Rivaroxaban | 68 | 16 |
| Prednisone | Prednisone | 67 | 42 |
| Myrbetriq | Mirabegron | 66 | 12 |
| Ondansetron Odt | Ondansetron | 66 | 25 |
| Clopidogrel | Clopidogrel Bisulfate | 65 | 24 |
| Mupirocin | Mupirocin | 65 | 15 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 64 | 32 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 61 | 18 |
| Citalopram Hbr | Citalopram Hydrobromide | 60 | 16 |
| Quetiapine Fumarate | Quetiapine Fumarate | 59 | 16 |
| Azelastine Hcl | Azelastine Hcl | 57 | 24 |
| Bupropion Xl | Bupropion Hcl | 57 | 16 |
| Fenofibrate | Fenofibrate | 57 | 14 |
| Oxybutynin Chloride | Oxybutynin Chloride | 57 | 13 |
| Clonidine Hcl | Clonidine Hcl | 56 | 15 |
| Colesevelam Hcl | Colesevelam Hcl | 56 | 17 |
| Doxepin Hcl | Doxepin Hcl | 55 | 11 |
| Fenofibrate | Fenofibrate,micronized | 54 | suppressed |
| Finasteride | Finasteride | 54 | 23 |
| Paroxetine Hcl | Paroxetine Hcl | 54 | 12 |
| Mounjaro | Tirzepatide | 52 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 50 | 11 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 50 | 12 |
| Linzess | Linaclotide | 50 | 16 |
| Estradiol | Estradiol | 49 | 21 |
| Lovastatin | Lovastatin | 48 | 12 |
| Propranolol Hcl | Propranolol Hcl | 47 | 13 |
| Trulicity | Dulaglutide | 47 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 47 | 23 |
| Aripiprazole | Aripiprazole | 46 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 46 | 13 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 46 | 16 |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 44 | 44 |
| Clobetasol Propionate | Clobetasol Propionate | 44 | 21 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 44 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 44 | 11 |
| Methadone Hcl | Methadone Hcl | 44 | suppressed |
| Telmisartan | Telmisartan | 44 | suppressed |
| Valsartan | Valsartan | 44 | suppressed |
| Lactulose | Lactulose | 42 | suppressed |
| Lidocaine | Lidocaine | 41 | 17 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 41 | 12 |
| Acyclovir | Acyclovir | 40 | 13 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 39 | 15 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 39 | 11 |
| Azithromycin | Azithromycin | 37 | 33 |
| Ondansetron Hcl | Ondansetron Hcl | 37 | 18 |
| Ketoconazole | Ketoconazole | 36 | 14 |
| Methylprednisolone | Methylprednisolone | 36 | 31 |
| Loperamide | Loperamide Hcl | 35 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 35 | 13 |
| Dicyclomine Hcl | Dicyclomine Hcl | 34 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 34 | 12 |
| Rexulti | Brexpiprazole | 34 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 34 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 32 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 32 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 31 | suppressed |
| Januvia | Sitagliptin Phosphate | 31 | 11 |
| Amoxicillin | Amoxicillin | 30 | 19 |
| Diazepam | Diazepam | 30 | 17 |
| Morphine Sulfate | Morphine Sulfate | 30 | 25 |
| Symbicort | Budesonide/Formoterol Fumarate | 30 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 29 | suppressed |
| Fenofibric Acid | Fenofibric Acid (Choline) | 29 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 29 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 29 | suppressed |
| Ursodiol | Ursodiol | 29 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 28 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 27 | 11 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 26 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 26 | 20 |
| Celecoxib | Celecoxib | 25 | suppressed |
| Cephalexin | Cephalexin | 25 | 21 |
| Glipizide Er | Glipizide | 25 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 25 | suppressed |
| Olanzapine | Olanzapine | 25 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 24 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 24 | 19 |
| Dexlansoprazole Dr | Dexlansoprazole | 24 | suppressed |
| Irbesartan | Irbesartan | 24 | suppressed |
| M-Natal Plus | Pnv,calcium 72/Iron/Folic Acid | 24 | suppressed |
| Eszopiclone | Eszopiclone | 23 | suppressed |
| Memantine Hcl | Memantine Hcl | 23 | suppressed |
| Primidone | Primidone | 23 | suppressed |
| Rybelsus | Semaglutide | 23 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 22 | suppressed |
| Hydrocortisone | Hydrocortisone | 22 | 14 |
| Morphine Sulfate Er | Morphine Sulfate | 22 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 21 | suppressed |
| Glyburide | Glyburide | 21 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 21 | suppressed |
| Movantik | Naloxegol Oxalate | 21 | suppressed |
| Sucralfate | Sucralfate | 21 | suppressed |
| Zaleplon | Zaleplon | 21 | suppressed |
| Carbamazepine | Carbamazepine | 20 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 20 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 19 | suppressed |
| Levetiracetam | Levetiracetam | 19 | suppressed |
| Naproxen | Naproxen | 19 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 18 | suppressed |
| Naloxone Hcl | Naloxone Hcl | 18 | 14 |
| Torsemide | Torsemide | 18 | suppressed |
| Repatha Sureclick | Evolocumab | 17 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 17 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 17 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 16 | suppressed |
| Guanfacine Hcl | Guanfacine Hcl | 16 | suppressed |
| Metronidazole | Metronidazole | 16 | 14 |
| Nucynta | Tapentadol Hcl | 16 | suppressed |
| Nystop | Nystatin | 16 | suppressed |
| Westab Plus | Pnv,calcium 72/Iron/Folic Acid | 16 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 15 | suppressed |
| Chlorthalidone | Chlorthalidone | 15 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 15 | suppressed |
| Methocarbamol | Methocarbamol | 15 | suppressed |
| Mupirocin | Mupirocin Calcium | 15 | suppressed |
| Prenatal Vitamin Plus Low Iron | Pnv,calcium 72/Iron/Folic Acid | 15 | suppressed |
| Progesterone | Progesterone, Micronized | 15 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 15 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 15 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 15 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 15 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 15 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 14 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 14 | suppressed |
| Glimepiride | Glimepiride | 14 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 14 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 14 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 14 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 13 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 13 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 13 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 13 | suppressed |
| Mesalamine | Mesalamine | 13 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Nurtec Odt | Rimegepant Sulfate | 13 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 13 | suppressed |
| Trospium Chloride | Trospium Chloride | 13 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 12 | suppressed |
| Atropine Sulfate | Atropine Sulfate | 12 | 12 |
| Creon | Lipase/Protease/Amylase | 12 | suppressed |
| Dexilant | Dexlansoprazole | 12 | suppressed |
| Diphenhydramine Hcl | Diphenhydramine Hcl | 12 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 12 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 12 | suppressed |
| Savella | Milnacipran Hcl | 12 | suppressed |
| Sumatriptan | Sumatriptan | 12 | suppressed |
| Xifaxan | Rifaximin | 12 | suppressed |
| Belsomra | Suvorexant | 11 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 11 | suppressed |
| Erythromycin | Erythromycin Base | 11 | suppressed |
| Glipizide | Glipizide | 11 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 11 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 11 | suppressed |
| Risedronate Sodium | Risedronate Sodium | 11 | suppressed |
| Scopolamine | Scopolamine | 11 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $6,700.52 · 8 records | Amgen Inc. | ENHERTU, NURTEC ODT, OTEZLA | 4 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Nurtec Odt play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error